Overview
Mark Rider practices in Brussels, Belgium. Mr. Rider is rated as an Experienced expert by MediFind in the treatment of Corticobasal Degeneration. His top areas of expertise are Hereditary Ovalocytosis, Hereditary Elliptocytosis, Adenosine Monophosphate Deaminase Deficiency, and Type 2 Diabetes (T2D).
His clinical research consists of co-authoring 47 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Corticobasal Degeneration.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adenosine Monophosphate Deaminase Deficiency
- Corticobasal DegenerationMr. Rider isExperienced. Learn about Corticobasal Degeneration.
- Hereditary ElliptocytosisMr. Rider isExperienced. Learn about Hereditary Elliptocytosis.
- Hereditary OvalocytosisMr. Rider isExperienced. Learn about Hereditary Ovalocytosis.
- Maturity Onset Diabetes of the YoungMr. Rider isExperienced. Learn about Maturity Onset Diabetes of the Young.
- Type 2 Diabetes (T2D)Mr. Rider isExperienced. Learn about Type 2 Diabetes (T2D).